|
|
Article: Merck KGaA Establishes U.S. Generic Pharmaceuticals Unit; Robert J. Mauro named president of New York-based Genpharm, L.P.
- Article from:
- Business Wire
- Article date:
- August 8, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK & DARMSTADT, Germany -- Merck KGaA announced today that it has established a generic pharmaceuticals business, Genpharm, L.P., in New York to provide direct access to customers in the United States.
"This will increase Merck's presence in the world's largest pharmaceutical market and will help solidify our position as the world's third-largest global generics company," said Hank Klakurka, CEO of the Merck Generics Group, a wholly owned business of Merck KGaA in Darmstadt, Germany.
Robert J. Mauro was named President of Genpharm, L.P. effective July 18, 2005, and will report directly to Klakurka. Mauro will be responsible for Merck's generics ...